vs
Cooper Companies (The)（COO）与大都会人寿（MET）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是大都会人寿的1.8倍（$1.1B vs $600.0M），大都会人寿净利率更高（134.8% vs 7.9%，领先126.9%），大都会人寿同比增速更快（7.9% vs 4.6%），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 2.0%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
大都会人寿（MetLife）是全球规模领先的保险、年金及员工福利服务提供商之一，创立于1868年，业务覆盖超60个国家和地区，服务约9000万客户，2018年位列《财富》美国500强营收排行榜第43位。
COO vs MET — 直观对比
营收规模更大
COO
是对方的1.8倍
$600.0M
营收增速更快
MET
高出3.3%
4.6%
净利率更高
MET
高出126.9%
7.9%
两年增速更快
COO
近两年复合增速
2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $600.0M |
| 净利润 | $84.6M | $809.0M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | — |
| 净利率 | 7.9% | 134.8% |
| 营收同比 | 4.6% | 7.9% |
| 净利润同比 | -28.0% | -36.3% |
| 每股收益（稀释后） | $0.42 | $1.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOMET
| Q4 25 | $1.1B | $600.0M | ||
| Q3 25 | $1.1B | $621.0M | ||
| Q2 25 | $1.0B | $604.0M | ||
| Q1 25 | $964.7M | $611.0M | ||
| Q4 24 | $1.0B | $556.0M | ||
| Q3 24 | $1.0B | $554.0M | ||
| Q2 24 | $942.6M | $558.0M | ||
| Q1 24 | $931.6M | $577.0M |
净利润COOMET
| Q4 25 | $84.6M | $809.0M | ||
| Q3 25 | $98.3M | $896.0M | ||
| Q2 25 | $87.7M | $729.0M | ||
| Q1 25 | $104.3M | $945.0M | ||
| Q4 24 | $117.5M | $1.3B | ||
| Q3 24 | $104.7M | $1.3B | ||
| Q2 24 | $88.9M | $946.0M | ||
| Q1 24 | $81.2M | $867.0M |
毛利率COOMET
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — | ||
| Q1 24 | 67.0% | — |
营业利润率COOMET
| Q4 25 | 13.2% | — | ||
| Q3 25 | 16.6% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 18.9% | — | ||
| Q4 24 | 19.5% | — | ||
| Q3 24 | 19.2% | — | ||
| Q2 24 | 17.2% | — | ||
| Q1 24 | 16.4% | — |
净利率COOMET
| Q4 25 | 7.9% | 134.8% | ||
| Q3 25 | 9.3% | 144.3% | ||
| Q2 25 | 8.7% | 120.7% | ||
| Q1 25 | 10.8% | 154.7% | ||
| Q4 24 | 11.5% | 228.6% | ||
| Q3 24 | 10.4% | 242.2% | ||
| Q2 24 | 9.4% | 169.5% | ||
| Q1 24 | 8.7% | 150.3% |
每股收益（稀释后）COOMET
| Q4 25 | $0.42 | $1.18 | ||
| Q3 25 | $0.49 | $1.22 | ||
| Q2 25 | $0.44 | $1.03 | ||
| Q1 25 | $0.52 | $1.28 | ||
| Q4 24 | $0.59 | $1.75 | ||
| Q3 24 | $0.52 | $1.81 | ||
| Q2 24 | $0.44 | $1.28 | ||
| Q1 24 | $0.41 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $25.6B |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $8.2B | $28.4B |
| 总资产 | $12.4B | $745.2B |
| 负债/权益比越低杠杆越低 | 0.30× | — |
8季度趋势，按日历期对齐
现金及短期投资COOMET
| Q4 25 | $110.6M | $25.6B | ||
| Q3 25 | $124.9M | $26.2B | ||
| Q2 25 | $116.2M | $27.5B | ||
| Q1 25 | $100.9M | $26.9B | ||
| Q4 24 | $107.6M | $25.2B | ||
| Q3 24 | $109.7M | $26.4B | ||
| Q2 24 | $112.4M | $24.6B | ||
| Q1 24 | $135.2M | $24.7B |
总债务COOMET
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益COOMET
| Q4 25 | $8.2B | $28.4B | ||
| Q3 25 | $8.4B | $28.9B | ||
| Q2 25 | $8.3B | $27.7B | ||
| Q1 25 | $8.1B | $27.5B | ||
| Q4 24 | $8.1B | $27.4B | ||
| Q3 24 | $7.9B | $30.9B | ||
| Q2 24 | $7.8B | $27.3B | ||
| Q1 24 | $7.7B | $28.5B |
总资产COOMET
| Q4 25 | $12.4B | $745.2B | ||
| Q3 25 | $12.4B | $719.7B | ||
| Q2 25 | $12.4B | $702.5B | ||
| Q1 25 | $12.2B | $688.3B | ||
| Q4 24 | $12.3B | $677.5B | ||
| Q3 24 | $12.1B | $705.0B | ||
| Q2 24 | $12.0B | $675.7B | ||
| Q1 24 | $12.0B | $677.6B |
负债/权益比COOMET
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $7.1B |
| 自由现金流经营现金流 - 资本支出 | $149.9M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 9.2% | — |
| 现金转化率经营现金流/净利润 | 2.93× | 8.75× |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COOMET
| Q4 25 | $247.9M | $7.1B | ||
| Q3 25 | $261.4M | $3.6B | ||
| Q2 25 | $96.2M | $2.2B | ||
| Q1 25 | $190.6M | $4.3B | ||
| Q4 24 | $268.1M | $4.6B | ||
| Q3 24 | $207.5M | $4.2B | ||
| Q2 24 | $111.0M | $3.5B | ||
| Q1 24 | $122.7M | $2.3B |
自由现金流COOMET
| Q4 25 | $149.9M | — | ||
| Q3 25 | $164.5M | — | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $101.2M | — | ||
| Q4 24 | $128.1M | — | ||
| Q3 24 | $118.5M | — | ||
| Q2 24 | $36.9M | — | ||
| Q1 24 | $4.6M | — |
自由现金流率COOMET
| Q4 25 | 14.1% | — | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 12.6% | — | ||
| Q3 24 | 11.8% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 0.5% | — |
资本支出强度COOMET
| Q4 25 | 9.2% | — | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 13.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | 12.7% | — |
现金转化率COOMET
| Q4 25 | 2.93× | 8.75× | ||
| Q3 25 | 2.66× | 3.98× | ||
| Q2 25 | 1.10× | 3.00× | ||
| Q1 25 | 1.83× | 4.51× | ||
| Q4 24 | 2.28× | 3.63× | ||
| Q3 24 | 1.98× | 3.11× | ||
| Q2 24 | 1.25× | 3.69× | ||
| Q1 24 | 1.51× | 2.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
MET
| Other | $165.0M | 28% |
| Prepaidlegalplansandadministrativeonlycontracts | $158.0M | 26% |
| Vision Fee For Service Arrangements | $140.0M | 23% |
| Administrative Service | $76.0M | 13% |
| Distribution Service | $36.0M | 6% |
| Feebasedinvestmentmanagementservices | $25.0M | 4% |
